期刊文献+

两种方法预处理多囊卵巢综合征对促排卵疗效观察 被引量:4

原文传递
导出
摘要 目的:观察多囊卵巢综合征(PCOS)不孕患者采用两种方法预处理后对促排卵的临床疗效。方法:将89例P-COS患者随机分成两组,甲组50例应用达英-35预处理2个周期后,予克罗米芬(CC)或克罗米芬+尿促性素(HMG)促排卵;乙组49例应用达英-35预处理3个周期后,同法促排卵。观察治疗前后内分泌指标的变化以及应用促排卵药物剂量及临床妊娠率。结果:两组不同方法预处理后LH、T较治疗前均有显著下降,两者间差异有统计学意义(P<0.05);所用促排卵药物剂量(HMG)及治疗天数,两组间差异有统计学意义(P<0.05);妊娠率两组间差异无统计学意义(P>0.05)。结论:应用达英-35预处理2个周期后促排卵治疗所用药物剂量少,治疗天数少,排卵率高,而不影响妊娠率。
出处 《中国妇幼保健》 CAS 北大核心 2011年第13期2015-2016,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献2

  • 1The Rotterdam ESHRE/ASRE -Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long - term health risks related to polyeystic ovarian syndrome (PCOS) [J]. Hum Reprod, 2004, 19 (1): 41.
  • 2Braniqan EF, Estes MA. A randomized clinical trial of treatment of clom- iphene citrate - resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment [ J] . Am J Ob- stet Gynecol, 2003, 188 (6): 1424.

同被引文献37

  • 1张学红,李丽斐,赵丽辉,石馨,贾学玲.应用不同剂量长效GnRHa(达菲林)降调节的临床效果分析[J].生殖与避孕,2005,25(7):435-437. 被引量:27
  • 2包晓晖.达英-35治疗多囊卵巢综合征30例临床观察[J].医药论坛杂志,2007,28(21):73-74. 被引量:5
  • 3Livadas S, Chaskou S, Kandaraki AA, et al. Anxiety is associated with hormonaland metabolic profile in women with polycystic ovarian syndrome[J]. Clin Endocrinol ( Oxf), 2011,75 (5) : 698 - 703.
  • 4Sumioki H, Utsunomiya T. Ovarian drilling//Kempers R, Cohen J, Haney AF,et al. Fertility and rep roduction medicine[M]. New York: Elsevier Science, 2007: 537 - 539.
  • 5Liang SJ, Hsu CS,Tzeng CR, et al. Clinical and bio- chemical presentation ofpolyeystic ovary syndrome in women between the ages of 20 and 40. Hum Reprod [J],2011 Sep 16. [Epub ahead of print].
  • 6Livadas S,Chaskou S,Kandaraki AA,et al.Anxiety is associated with hormonaland metabolic profile in women with polycystic ovarian syndrome[J].Clin Endocrinol(Oxf),2011,75(5):698-703.
  • 7Sumioki H,Utsunomiya T.Fertility and rep roduction medicine[J].Elsevier Science,2007,32(12):537-539.
  • 8Kim JW,Han JE,Kim YS,et al.High sensitivity C-reactive protein and itsrelationship with impaired glucose regulation in lean patients with polycysticovary syndrome[J].Gynecol Endocrinol,2012,28(4):259-263.
  • 9Skaiba P,Cygal A,Madej P,et al.Is the plasma anti-Miillerian hormone(AMH)level associated with body weight and metabolic,and hormonal disturbances inwomen with and without polycystic ovary syndrome?[J].Eur J Obstet Gynecol Reprod Biol,2011,158(2):254-259.
  • 10Liang SJ,Hsu CS,Tzeng CR,et al.Clinical and biochemical presentation ofpolycystic ovary syndrome in women between the ages of 20 and 40[J].Hum Reprod,2011,26(12):3443-3449.

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部